[Helicobacter pylori-New aspects of forthcoming guidelines].

4区医学 Q3 Medicine

Internist Pub Date : 2022-04-01 Epub Date: 2022-03-01 DOI:10.1007/s00108-022-01275-2

Christian Schulz, Wolfgang Fischbach, Michael Sigal, Kerstin Schütte, Sebastian Suerbaum, Peter Malfertheiner

引用次数: 0

Abstract

The diagnostics and treatment of Helicobacter pylori infections are subject to continuous changes and adaptations. Due to the increase of resistance rates to frequently used antibiotics, especially clarithromycin and the lack of new antibacterial substances as well as new developments in the diagnostics, particularly new procedures for resistance testing, the guidelines have to be updated regularly. In this article new directions and trends of the forthcoming European and German guidelines are summarized, categorized and discussed by the authors involved in the compilation of future guidelines.

查看原文本刊更多论文

[幽门螺杆菌——即将出台的指南的新方面]。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Internist 医学-医学：内科

CiteScore

1.20

自引率

0.00%

发文量

139

审稿时长

4-8 weeks

期刊介绍： Der Internist is an internationally respected journal dealing with all aspects of internal medicine. The journal serves both the scientific exchange and the continuing education of internists working in practical or clinical environments as well as of general practitioners who are particularly interested in internal medicine. The focus is on the topics of prevention, diagnostic approaches, management of complications, and current therapy strategies. Comprehensive reviews on a specific topical issue focus on providing evidenced based information on diagnostics and therapy. Case reports feature interesting cases and aim at optimizing diagnostic and therapeutic strategies. Review articles under the rubric "Continuing Medical Education" present verified results of scientific research and their integration into daily practice.